Google AI ModeOct 2, 2026
Data as of Oct 18, 2026Based on 315 AI responses from ChatGPT Search and Google AI Mode
Reviewed by Dimitry Apollonsky
AI summary
For most SaaS and tech founders seeking pre-IPO capital, Insight Partners is the best fit: it routinely writes large late-stage checks and has a strong record taking software companies to IPO. If you need an aggressive, fast lead investor, consider Tiger Global; for long-term strategic partnership and broad-stage backing, consider Sequoia or a16z.
Explore the market rankingInvestment Services and Capital Providers
Brands AI recommends here
Mentioned in · Sep 16 – Oct 2, 2026
Google AI ModeOct 2, 2026
ChatGPT SearchOct 2, 2026
ChatGPT SearchSep 28, 2026
Google AI ModeSep 28, 2026
Google AI ModeSep 24, 2026
ChatGPT SearchSep 24, 2026
Google AI ModeSep 20, 2026
ChatGPT SearchSep 20, 2026
Google AI ModeSep 16, 2026
ChatGPT SearchSep 16, 2026
0% of citations to these sources link to brands' own websites.
vcsheet.com
growthequityinterviewguide.com
When looking at late-stage venture capital and crossover financing, "pre-IPO" checks are heavily concentrated among top-tier growth funds , traditional venture heavyweights with dedicated growth arms, and crossover hedge funds. Rather than spreading capital widely across early-stage experiments, late-stage deployment is heavily concentrated in category-defining, high-capital-intensity sectors (predominantly frontier AI, aerospace/defense, and deep enterprise infrastructure).[](https://etfdb.com/thematic-investing-content-hub/pre-ipo-private-growth-etfs/)[[2](https://valueaddvc.com/blog/crossover-investing-in-2026-2209b-in-pre-ipo-deals-and-why-its-concentrated-in-178-rounds)](https://valueaddvc.com/blog/crossover-investing-in-2026-2209b-in-pre-ipo-deals-and-why-its-concentrated-in-178-rounds)
The most prominent and active players writing massive late-stage and pre-IPO checks include:
If you'd like, let me know:
I can narrow down check sizes and typical deal structures for you.
If by “pre-IPO checks” you mean roughly $25M–$500M+ primary/growth investments into already-scaled private companies, including late Series D–H, growth rounds, crossover rounds and IPO-bridge financings, the market is concentrated among a fairly small group.
There isn't a clean industry-wide league table, but recent 2026 deal data points to the following group as the most consistently active:
| Investor | What stands out | Recent evidence |
|---|---|---|
| Coatue | One of the strongest pure late-stage/crossover check writers; particularly aggressive in AI, fintech and software | Its portfolio includes Anthropic, Notion, Hugging Face, Deel, Fireblocks and others; it led Kalshi's $1B Series F in 2026. |
| Insight Partners | Probably the most purpose-built scale-up / software investor in this group; substantial ability to lead and follow on | TechStackIPO tracks 22 lead placements / 25 deals in its current pre-IPO universe; Insight also recently expanded its secondaries operation. |
| General Atlantic | Large growth-equity checks, including companies immediately approaching public markets | Its current pre-IPO portfolio includes Shein, Canva, Grafana Labs and Faire; it was also among the investors covered by Shein's IPO-related preferred-share protections. |
| Thrive Capital | Very large concentrated bets in elite private tech companies | Current pre-IPO exposure includes OpenAI, Databricks, Ramp, Cursor and Airtable. |
| Tiger Global | Historically one of the highest-volume private tech/crossover investors | TechStackIPO currently tracks 50 lead placements across 53 active pre-IPO companies. |
| a16z | Enormous late-stage capacity; increasingly active in frontier AI/defense | TechStackIPO puts it at 92 lead placements / 103 deals across its active pre-IPO universe. |
| Sequoia | Very high activity, particularly as a lead in large technology rounds | 77 lead placements / 81 deals in TechStackIPO's current universe; recent private-market data also has Sequoia among the most active lead investors. |
| General Catalyst | Increasingly active across very large late-stage/AI rounds | 25 lead placements / 36 deals in the current pre-IPO universe, including Mistral AI, Saronic, Rapyd and Glean. |
| Lightspeed | Strong recent momentum in huge late-stage AI/software financings | 21 lead placements / 21 deals; it led Temporal's $550M Series E in September 2026. |
| NEA | Large multi-stage platform with meaningful late-stage capacity | Current tracked exposure includes Databricks, Perplexity, Robinhood and Anyscale. |
| IVP | Particularly relevant for mature enterprise/software companies | Current pre-IPO exposure includes Perplexity and Niantic; it participated in Kalshi's $1B Series F. |
| ICONIQ Growth | Strong enterprise SaaS/growth orientation and increasingly large secondary/growth transactions | Its 2026 activity includes a $400M NinjaOne secondary transaction and participation in Hightouch's $150M Series D. |
If you're looking for a $100M+ lead:
If you're a SaaS / enterprise company approaching IPO:
Insight, General Atlantic, ICONIQ Growth, IVP, TCV, NEA are especially relevant.
If you're an AI company:
Coatue, a16z, Sequoia, Thrive, General Catalyst, Lightspeed, NEA are particularly prominent in the current late-stage pipeline. TechStackIPO's 2026 data shows these firms repeatedly appearing across AI companies approaching IPO scale.
If you specifically mean crossover/public-market investors rather than VC/growth funds:
Add Dragoneer, D1 Capital, Altimeter, Fidelity, T. Rowe Price, Wellington, Capital Group and BlackRock. Their behavior is somewhat different: they are more likely to participate in enormous late-stage rounds, structured financings or secondary transactions rather than behave like a traditional VC lead.
One interesting data point: Ramp's June 2026 $726.9M Series F at a $44B valuation included an unusually broad syndicate spanning Coatue, Thrive, General Catalyst, Founders Fund, Insight, ICONIQ, Lightspeed and several crossover/public-market institutions. That's a good illustration of what the current "pre-IPO" market actually looks like.
My practical shortlist for sourcing a pre-IPO round would therefore start with ~10 names: Coatue, Insight, General Atlantic, Thrive, a16z, Sequoia, General Catalyst, Tiger Global, ICONIQ Growth and Lightspeed—then add IVP/NEA/TCV/Dragoneer depending on sector and whether you need a lead or follower.
One caveat: TechStackIPO's activity index is based on disclosed lead and follow-on placements across 460+ active pre-IPO companies, so it is useful for measuring activity, but it isn't a definitive ranking of dollars deployed or average check size.
If you're asking this from a fundraising/sourcing perspective, I can take the next step and build a 25-fund matrix with estimated check size, recent 2025–26 pre-IPO deals, lead vs. follow behavior, sector focus, and which funds are most likely to write $50M / $100M / $250M+ checks.
If by “pre-IPO checks” you mean $50M–$500M+ investments into late-stage private companies (often Series D–H, growth rounds, tender offers, or IPO bridge rounds), the market is dominated by a relatively small set of growth VC, crossover, and hybrid investment firms. There is no universally accepted league table, but these firms consistently show up in the largest late-stage financings.
| Investor | Typical role | Where they are especially active |
|---|---|---|
| Coatue Management | Crossover / growth lead or co-lead | AI, enterprise software, internet, mega-rounds; often writes very large checks |
| Insight Partners | Growth equity lead | Enterprise software, cybersecurity, SaaS companies approaching IPO scale |
| General Atlantic | Growth investor | Large technology, fintech, healthcare, consumer growth companies |
| ICONIQ Capital / ICONIQ Growth | Growth lead | B2B software, infrastructure, fintech, founder-led companies |
| TCV | Classic late-stage tech investor | SaaS, marketplaces, internet companies near public-market readiness |
| Dragoneer Investment Group | Crossover / growth investor | Large private technology rounds and secondary transactions |
| Thrive Capital | Multi-stage VC with large late-stage capacity | AI, consumer internet, software, category-defining companies |
| Tiger Global Management | Crossover investor | Historically one of the most aggressive late-stage check writers; now more selective than during 2020–21 |
| DST Global | Crossover / growth | Large internet and technology companies |
| Andreessen Horowitz (a16z) | Multi-stage VC | AI, crypto, fintech, enterprise; participates in very large late rounds |
| Sequoia Capital | Multi-stage VC | High-conviction follow-ons into breakout companies |
| General Catalyst | Multi-stage/growth | Enterprise, healthcare, fintech, AI |
Parse## If you are a company raising a late-stage round
A practical target list depends heavily on round size:
Common targets:
Common targets:
The investor set often expands beyond VC into crossover/public-market institutions:
Large asset managers increasingly participate when private companies are already valued in the tens of billions and the financing resembles a bridge toward public markets.
For a founder trying to run a pre-IPO process, the “most active” list is usually less important than matching:
If you share the sector, current valuation, revenue scale, and desired check size, I can narrow this to the likely top 10–15 investors and distinguish lead investors vs. likely followers.
When looking at late-stage and growth-tier financing designed to bridge companies right up to public market debuts (pre-IPO or massive Series C/D+ rounds), the ecosystem relies on a mix of dedicated multi-stage venture capital heavyweights, specialized growth equity funds, and public-to-private crossover investors.[](https://www.intralinks.com/guides/fundraising-rounds-explained)
The most prominent and active institutional players writing substantial pre-IPO and late-stage checks include:
If you are targeting a specific sector (like AI, fintech, or enterprise SaaS) or looking for a precise check size range , I can narrow down which of these funds are most active in that exact niche.
Writing massive "pre-IPO" or crossover checks requires enormous dedicated late-stage growth pools, patience with longer private-company life cycles, and the firepower to deploy $25M to $200M+ per round.[](https://www.intralinks.com/guides/fundraising-rounds-explained)
The late-stage venture capital funds, growth arms, and crossover-style mega-VCs most active in writing these major pre-IPO checks include:
If you're targeting a specific sector (like AI infrastructure, fintech, or enterprise SaaS) or looking for a particular check size range , I can narrow down which of these funds are most active in that exact niche.
If by “pre-IPO check” you mean a $25M–$500M+ primary or secondary investment into a company that is roughly 12–36 months from public-market readiness, the active universe is fairly concentrated.
As of 2025–26, I’d put these firms on the first-call list:
| Investor | Typical role | Approx. late-stage check profile | Why it stands out |
|---|---|---|---|
| Coatue | Lead / co-lead | $75M–$500M+ | Extremely active in mega-rounds and crossover investing; recent participation includes Anthropic, Databricks, Replit and other IPO-scale companies. |
| ICONIQ Growth | Lead / co-lead | $50M–$500M+ | Explicitly operates across growth-stage companies through IPO; invested $4.8B across 48 companies in 2025 according to its reported activity, and led Anthropic's $13B Series F. |
| Insight Partners | Lead / co-lead | $50M–$300M+ | One of the most established late-stage specialists; its database-driven strategy has historically focused heavily on pre-IPO technology investments. |
| General Atlantic | Lead / co-lead | $50M–$300M+ | Classic growth-equity/pre-IPO investor; its strategy explicitly targets mature private companies approaching IPO. It remains active in very large rounds such as Anthropic. |
| DST Global | Lead / co-lead | $100M–$500M+ | Particularly active in very large internet/technology rounds; for example, DST led Higgsfield's $400M Series B in August 2026. |
| Dragoneer | Lead / co-lead | $100M–$500M+ | Major crossover/growth investor increasingly showing up in IPO-scale financings; participated in the enormous 2026 Anthropic rounds. |
| TCV | Lead / co-lead | $50M–$250M+ | Longstanding technology growth investor with a large late-stage portfolio and substantial capacity. |
| IVP | Lead / co-lead | $50M–$250M+ | Traditional late-stage VC/growth specialist; particularly relevant for software/internet companies approaching an IPO. |
| Thrive Capital | Lead / participant | $100M–$500M+ | More concentrated than the dedicated growth funds, but increasingly relevant for enormous late-stage technology rounds. |
| Tiger Global | Lead / participant | $50M–$400M+ | Historically one of the most aggressive pre-IPO investors; still appears in late-stage deals, including Shein's pre-IPO financing. |
There are really three different markets hiding under “pre-IPO.”
1. $25–100M institutional growth round
Think Insight, IVP, TCV, ICONIQ Growth, General Atlantic, Lightspeed.
These are the firms I'd expect to have a relatively conventional growth-equity underwriting process: ARR, growth rate, margins, retention, TAM, IPO comparables, governance, etc.
2. $100–500M IPO-bridge / crossover round
Think Coatue, ICONIQ, General Atlantic, Dragoneer, DST, Thrive, Tiger.
Here the investor is increasingly underwriting the company almost like a public-market security. Recent Anthropic financings are an unusually clear example: Coatue, Dragoneer, ICONIQ, DST and other crossover investors have repeatedly participated in the company's enormous late-stage rounds.
3. $500M+ mega-round
At this point, the buyer universe expands beyond conventional VC into crossover funds and giant asset managers: Coatue, Dragoneer, DST, GIC, Fidelity, Capital Group, BlackRock, T. Rowe Price, D.E. Shaw, etc. The 2026 Anthropic rounds illustrate this shift particularly well.
I'd distinguish “most active” from “most likely to lead my particular round.” For example:
One useful data point: a current database of late-stage investors puts Insight at 1,349 late-stage investments, while the broader universe also includes firms such as Lightspeed, Bessemer, Kleiner Perkins and TCV.
My practical takeaway: if you're building a target list for a real pre-IPO process, I'd start with Coatue, ICONIQ Growth, Insight, General Atlantic, TCV, IVP, DST and Dragoneer, then add crossover/asset-manager capital depending on round size and valuation. The exact ordering depends heavily on whether you're looking for a lead, a co-investor, or a secondary buyer—and whether you're talking SaaS, fintech, consumer, biotech, or AI.
Late-stage and pre-IPO checks (often deployed by hybrid "crossover" investors and dedicated growth-equity arms) focus heavily on mature, de-risked private companies with a clear line of sight to public markets.[](https://www.nb.com/insights/article-harvesting-the-valuation-gap-the-strategic-role-of-crossover-equity)[[2](https://www.startups.com/lexicon/crossover-investor)](https://www.startups.com/lexicon/crossover-investor)
Activity in this space is heavily concentrated in massive, high-conviction rounds (particularly in AI, enterprise infrastructure, and fintech) rather than a scattershot spray-and-pray approach. The most active and prominent players writing large late-stage/pre-IPO checks include:[](https://valueaddvc.com/blog/crossover-investing-in-2026-2209b-in-pre-ipo-deals-and-why-its-concentrated-in-178-rounds)
If you're looking into a specific sector (like AI/infrastructure vs. fintech ), I can share more tailored data on which of these funds are leading rounds in that exact vertical.
If by “pre-IPO checks” you mean $50M–$500M+ primary rounds into companies that are already at late growth / IPO-candidate scale, the active universe in 2025–26 looks roughly like this. There isn't a clean public league table, so I’d treat this as a market map rather than a definitive ranking.
These aren't all “pre-IPO funds” in the narrow sense, but their capacity to follow companies into $100M–$1B+ private rounds makes them relevant competitors for the same deals. DST, for example, has been particularly active in enormous private technology financings.
This has become increasingly important. Fidelity, BlackRock, Franklin Templeton, T. Rowe Price and other large institutional managers have increasingly appeared alongside VC/growth firms in late-stage rounds. In 2025, for example, Franklin Templeton led Plaid's $575M financing, while BlackRock co-led Applied Intuition's $600M round.
The broader market is getting substantially larger: U.S. “growth stage” companies raised $126.9B across 937 deals in 2025, according to NVCA/PitchBook data, with many of those rounds effectively serving as pre-IPO financings without an IPO immediately following.
I'd segment the target list by check size and company maturity, rather than simply calling all of these “pre-IPO”:
| Investor type | Typical useful target | Best fit |
|---|---|---|
| Coatue / GA / Dragoneer | $100–500M+ | $5B–$50B+ companies |
| Insight / TCV / IVP / ICONIQ | $50–300M | Enterprise software / fintech |
| Tiger / DST / Altimeter | $100M–$1B+ | Exceptional, very large private companies |
One important distinction: “most active” can mean number of deals, dollars deployed, or willingness to lead a $100M+ primary round. Those produce materially different lists. The publicly available data suggest Coatue, Insight, GA, TCV, Dragoneer and the major crossover firms are particularly important if your definition is actual late-stage primary checks, rather than secondary/pre-IPO share purchases.
If you're looking at this from a fundraising/sourcing perspective, I can also build a more useful 2025–26 investor matrix with ~25 funds, recent deals, estimated check size, sectors, lead-vs-participate behavior, and evidence of IPO-stage investing.
When looking at late-stage and "pre-IPO" check writers, the lines between traditional venture capital, growth equity, and public-market crossover funds often blur . The firms most active in writing massive, pre-public checks are typically mega-funds or Registered Investment Advisers (RIAs) capable of deploying tens or hundreds of millions to bridge the gap between late-stage private rounds and public market debuts.[](https://www.rho.co/blog/late-stage-vc)
The most prominent and active players writing heavy pre-IPO and crossover checks include:
If you're targeting a specific sector (like AI, biotech, or fintech) or looking for funds active in a certain geographic region , I can narrow down which of these players are most relevant to your goals.
The most active late-stage investors writing “pre-IPO” checks (large growth rounds, crossover financings, IPO bridge rounds, and late private secondaries) are generally a mix of growth VC firms and crossover/public-market investors. There is no single public ranking, but the recurring leaders are:
| Fund | Typical pre-IPO role |
|---|---|
| Coatue Management | One of the most visible crossover investors; frequently participates in $100M+ late-stage technology rounds, especially AI, software, fintech, and internet companies. |
| Insight Partners | Major late-stage software/growth investor; often leads large Series C–pre-IPO rounds in enterprise software and cybersecurity. |
| General Atlantic | Long-standing growth investor with capacity for very large checks into companies approaching public markets. |
| Dragoneer Investment Group | Concentrated late-stage tech investor; frequently appears in mega-round syndicates. |
| ICONIQ Capital | Strong in enterprise software, SaaS, and fintech growth rounds; invests across stages through IPO. |
| TCV | Classic late-stage technology investor with a long history of backing companies before IPOs. |
| Thrive Capital | Increasingly important in very large private technology rounds, particularly AI and internet. |
| Tiger Global Management | Historically one of the most aggressive late-stage check writers; now more selective than during the 2020–21 peak. |
| Andreessen Horowitz | Not purely a pre-IPO fund, but its growth strategy can participate in very large late-stage financings. |
| Lightspeed Venture Partners | Active late-stage participant, especially in AI and infrastructure. |
A useful segmentation:
If you mean who is most likely to lead a $50M–$200M Series D/E round vs. who buys secondary shares from employees, the list changes somewhat.
| Thrive / a16z / GC / Lightspeed | $50–500M+ | AI, infrastructure, software |
| Fidelity / BlackRock / Franklin / T. Rowe | $50–500M+ | Mature companies with credible IPO path |